Blogs
Our Blogs
How to Prepare Your Facility for a Regulatory Audit
Regulatory audits are among the most critical events in the lifecycle of any pharmaceutical, biotechnology, or medical device organization. A successful audit outcome not only…
GLP Auditing Services – OECD & FDA Compliance for Canada, USA & Global Markets
Why GLP Auditing Is a Regulatory Imperative Good Laboratory Practice (GLP) is the backbone of nonclinical safety testing. Whether you follow the OECD Principles of GLP…
EU GMP Annex 1: Mastering Contamination Control Strategy and Audit Readiness
The 2022 revision of EU GMP Annex 1 for sterile medicinal products has raised the bar for contamination control. It is no longer enough to…
From Cyclotron to Patient: Radiopharmaceuticals Manufacturing
If you work in nuclear medicine or radiopharmacy, you already know this. Making a radiopharmaceutical is not like manufacturing regular drugs. You are not working…
OECD GLP Auditing I GLP Audit I Sponsor GLP Audits I GLP I
In non-clinical health and environmental safety, OECD Good Laboratory Practice (GLP) is the leading standard. For pharmaceutical, chemical, and agrochemical companies, as well as CROs…
Chemistry, Manufacturing, and Controls (CMC) QA Services
In the rapidly evolving pharmaceutical and biotechnology sectors, sponsor companies encounter a significant challenge: maintaining comprehensive control over Chemistry, Manufacturing, and Controls (CMC) when manufacturing…
The Critical Role of Sponsor Oversight: Mastering GLP Audits with Certified Expertise
Integrity is essential in drug development. Pharmaceutical and biotechnology companies must ensure that non-clinical studies comply with Good Laboratory Practice (GLP) to support successful regulatory…
Good Distribution Practices (GDP) Auditing
Beyond the Warehouse: Elevating Your Supply Chain with a Robust GDP Audit In the pharmaceutical industry, the journey of a product from the manufacturing line…
GLP Auditing Services: Ensuring Compliance with 21 CFR Part 58 & OECD Standards
GLP Auditing Services: Ensuring Compliance with 21 CFR Part 58 & OECD Standards In drug development, the integrity of non-clinical data is essential. Good Laboratory…
